Skip to main content
. 2021 Oct 14;16(10):e0258426. doi: 10.1371/journal.pone.0258426

Fig 2. In vitro time kill curves of ceftazidime/avibactam (CEF/AVI), amikacin (AMK), colistin (COL) and tigecycline (TGC) alone and in combinations against KPC-K. pneumoniae isolates susceptible to ceftazidime/avibactam, amikacin, colistin and tigecycline.

Fig 2

Line for blank control, CEF/AVI, ○AMK, ◇COL, □TGC, ●CEF/AVI+AMK, ◆CEF/AVI+COL, ■CEF/AVI+TGC.